Iradimed (NASDAQ:IRMD) Releases Q4 2024 Earnings Guidance

Iradimed (NASDAQ:IRMD) updated its fourth quarter 2024 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.420-0.450 for the period, compared to the consensus estimate of 0.400. The company issued revenue guidance of $18.8 million-$19.2 million, compared to the consensus revenue estimate of $19.3 million. Iradimed also updated its FY 2024 guidance to 1.640-1.670 EPS.

Wall Street Analysts Forecast Growth

Separately, Roth Mkm lowered their target price on Iradimed from $65.00 to $60.00 and set a “buy” rating for the company in a research note on Friday, August 2nd.

Iradimed Trading Down 2.0 %

IRMD stock traded down $0.97 during trading on Friday, hitting $48.30. The company had a trading volume of 32,944 shares, compared to its average volume of 28,110. The business has a 50-day moving average of $48.98 and a 200-day moving average of $45.56. Iradimed has a one year low of $39.24 and a one year high of $53.99. The stock has a market cap of $611.96 million, a PE ratio of 33.08 and a beta of 0.79.

Iradimed (NASDAQ:IRMD) last announced its earnings results on Thursday, August 1st. The medical equipment provider reported $0.38 EPS for the quarter, beating the consensus estimate of $0.33 by $0.05. Iradimed had a return on equity of 24.59% and a net margin of 26.12%. The business had revenue of $17.93 million for the quarter, compared to analysts’ expectations of $17.70 million. During the same period in the prior year, the business posted $0.33 earnings per share. Research analysts forecast that Iradimed will post 1.47 EPS for the current year.

Iradimed Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, November 25th. Investors of record on Friday, November 15th will be issued a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 1.24%. The ex-dividend date is Friday, November 15th. Iradimed’s payout ratio is presently 41.10%.

About Iradimed

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.